Manske Wealth Management
Source: SEC Form 13F · as of Mar 2026Manske Wealth Management holds 15 biotech & pharma companies tracked by BioSniper, totaling $12.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$12.9M
| Company | Shares | Value |
|---|---|---|
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 38,569 | $2.1M |
| MRKMerck & Co., Inc. | 12,709 | $1.5M |
| PFEPFIZER INC | 53,724 | $1.5M |
| BMYBRISTOL MYERS SQUIBB CO | 23,282 | $1.4M |
| GILDGILEAD SCIENCES, INC. | 8,546 | $1.2M |
| PMPhilip Morris International Inc | 6,504 | $1.1M |
| JNJJOHNSON & JOHNSON | 2,629 | $643K |
| NVONovo Nordisk A/S | 17,173 | $631K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,189 | $592K |
| LLYELI LILLY & Co | 605 | $556K |
| SNYSanofi | 10,812 | $521K |
| ABBVAbbVie Inc. | 1,869 | $406K |
| MCKMcKesson Corporation | 379 | $328K |
| CAHCardinal Health Inc. | 1,439 | $304K |
| GRFSGrifols S.A. | 11,548 | $93K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.